Amgen Replaces Two Top Executives, Beats Quarterly Estimates

(Bloomberg) -- Amgen Inc. shook up its C-suite on Thursday with two major changes as the biotechnology company searches for new therapies to replace fading blockbusters facing strong competition.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.